OD-doxy-PNV-COVID-19 Old Drug " DOXY " for Prevention of New Virus " COVID-19 "
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Given the urgency of having guidelines for the management of COVID-19 in the current epidemic
context and the lack of specific pharmacological treatment, Military Health recommends the
launch of a multicenter, randomized, double-blind, interventional clinical trial.
The aim of this study is to evaluate the efficacy of a combination of two treatments,
low-dose doxcycline (100 mg/day) and Zinc (15 mg/day) (dietary supplement) in the primary
prevention of COVID-19 infection in health care professionals in Tunisia compared to two
control groups.